Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 4,433 | 2,721 |
| Other current assets | 164 | 676 |
| TOTAL | $4,597 | $3,397 |
| Non-Current Assets | ||
| PPE Net | 4,405 | 2,464 |
| Other Non-Current Assets | 199 | 381 |
| TOTAL | $4,604 | $2,845 |
| Total Assets | $9,403 | $6,242 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 338 | 414 |
| Accrued Expenses | 171 | 331 |
| Other current liabilities | 250 | 0 |
| TOTAL | $1,596 | $1,066 |
| Non-Current Liabilities | ||
| TOTAL | $2,395 | $1,274 |
| Total Liabilities | $3,991 | $2,341 |
| Shareholders' Equity | ||
| Common Shares | 18 | 11 |
| Retained earnings | -6,224 | -1,894 |
| Other shareholders' equity | 72 | 53 |
| TOTAL | $5,412 | $3,901 |
| Total Liabilities And Equity | $9,403 | $6,242 |